The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I dose escalation and expansion study of defactinib, pembrolizumab, and gemcitabine in patients with advanced treatment-refractory pancreatic cancer.
 
Andrea wang-gillam
Employment - Jacobio
Stock and Other Ownership Interests - Jacobio
Consulting or Advisory Role - AstraZeneca; Bayer; Inxmed; Merck
Research Funding - AstraZeneca (Inst); BioMed Valley Discoveries (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Gossamer Bio (Inst); Hutchison MediPharma (Inst); Lilly (Inst); Merck (Inst); pfizer (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Verastem (Inst); Xcovery (Inst)
 
Kian-Huat Lim
Honoraria - Jacobio
Research Funding - Aclaris Therapeutics
 
Robert R. McWilliams
Stock and Other Ownership Interests - Zentalis
Consulting or Advisory Role - Zentalis
Research Funding - Bristol-Myers Squibb (Inst); GlaxoSmithKline/Tesaro (Inst); Merck (Inst); Newlink Genetics (Inst)
 
Rama Suresh
No Relationships to Disclose
 
A. Craig Lockhart
Consulting or Advisory Role - Novartis
Research Funding - Amgen (Inst)
 
Amberly Brown
No Relationships to Disclose
 
John Herndon
No Relationships to Disclose
 
Katrina Sophia Pedersen
Consulting or Advisory Role - Array BioPharma; Bayer; Novartis; Pfizer
Speakers' Bureau - Clinical Care Options; WebMD
Research Funding - Abbvie (Inst); Arcus Biosciences (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo/Lilly (Inst); Ipsen (Inst); Merck (Inst); Natera (Inst); Nouscom (Inst); Novartis (Inst); Pfizer (Inst); Rafael Pharmaceuticals (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Array BioPharma; BeiGene; Nouscom
Other Relationship - UpToDate
(OPTIONAL) Uncompensated Relationships - NCCN
 
Benjamin R. Tan
Research Funding - Adaptimmune (Inst); Agios (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst); Roche/Genentech (Inst); TYME (Inst)
 
Nicolas Boice
No Relationships to Disclose
 
Mina Abdiannia
No Relationships to Disclose
 
Feng Gao
No Relationships to Disclose
 
Harry H. Yoon
Consulting or Advisory Role - ALX ONCOLOGY; Astellas Scientific and Medical Affairs Inc; AstraZeneca; BeiGene; Bristol-Myers Squibb; LSK Biopharma; Macrogenics; Merck; Novartis; OncXerna Therapeutics; Zymeworks
Research Funding - Boston Biomedical (Inst); Lilly/ImClone (Inst); Merck (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Lilly
 
Mojun Zhu
No Relationships to Disclose
 
Nikolaos A. Trikalinos
No Relationships to Disclose
 
Lee Ratner
No Relationships to Disclose
 
Olivia Aranha
Research Funding - Ipsen (Inst); Merck (Inst); Pfizer (Inst)
 
William G. Hawkins
Patents, Royalties, Other Intellectual Property - I am on the BOD for Accuronix Therapuetics
 
Brett Herzog
No Relationships to Disclose
 
David G. DeNardo
Consulting or Advisory Role - Verastem